Free Trial

Anthem (NASDAQ:ANTX) Raised to "Hold" at Wall Street Zen

Anthem logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Anthem (NASDAQ:ANTX) from a "sell" to a "hold", while Weiss Ratings initiated coverage with a "sell (d-)" and the MarketBeat consensus rating remains a Hold with a $2.00 target price.
  • Anthem is currently unprofitable—reporting ($0.29) EPS last quarter and analysts expect -0.91 EPS for the year—and is a small-cap company (market cap ≈ $168.5M) with a one-year trading range of $1.00 to $6.91 (opened at $4.68).
  • Interested in Anthem? Here are five stocks we like better.

Anthem (NASDAQ:ANTX - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued to investors on Sunday.

Separately, Weiss Ratings began coverage on shares of Anthem in a report on Tuesday, April 7th. They issued a "sell (d-)" rating for the company. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $2.00.

Check Out Our Latest Research Report on Anthem

Anthem Price Performance

Shares of ANTX opened at $4.68 on Friday. Anthem has a 1-year low of $1.00 and a 1-year high of $6.91. The firm's 50 day simple moving average is $3.38 and its 200 day simple moving average is $1.93. The company has a market capitalization of $168.46 million, a P/E ratio of -4.03 and a beta of -0.96.

Anthem (NASDAQ:ANTX - Get Free Report) last issued its earnings results on Tuesday, March 17th. The company reported ($0.29) earnings per share (EPS) for the quarter. On average, equities analysts anticipate that Anthem will post -0.91 earnings per share for the current year.

About Anthem

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anthem Right Now?

Before you consider Anthem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anthem wasn't on the list.

While Anthem currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines